Drug Profile
Research programme: anti-SDF-1 antibodies - Medarex/Ono
Alternative Names: Research programme: anti-stromal cell-derived factor-1 antibodies - Medarex/OnoLatest Information Update: 29 Sep 2009
Price :
$50
*
At a glance
- Originator Medarex; Ono Pharmaceutical
- Class Antibodies
- Mechanism of Action Chemokine CXCL12 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 29 Sep 2009 No development reported - Preclinical for Undefined indication in Japan (unspecified route)
- 29 Sep 2009 No development reported - Preclinical for Undefined indication in USA (unspecified route)
- 30 Mar 2006 Preclinical trials in Undefined in Japan (unspecified route)